Authors: EUROPEAN SOCIETY OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES FEBRUARY 11, 2022 New research to be presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2022, Lisbon, April 23-26) suggests that many of the symptoms connected to post-COVID syndrome (PCC, also known as long COVID) could be linked to the effect of the […]
Authors: Eyad Abuelgasim,Ann Christine Modaragamage Dona,Rajan Singh Sondh,Amer Harky First published: 28 September 2020 https://doi.org/10.1111/dth.14328 Abstract The global pandemic COVID-19 has resulted in significant global morbidity, mortality and increased healthcare demands. There is now emerging evidence of patients experiencing urticaria. We sought to systematically review current evidence, critique the literature, and present our findings. Allowing PRISMA […]
Authors: Dagnia Zeidlickis, Vice President, Communications | zeidlick@cshl.edu | 516-367-8455 A high dose of famotidine, commonly known as Pepcid®, was found to have beneficial effects in adult patients with coronavirus disease 2019 (COVID-19), according to results of an outpatient clinical trial. Patients who took famotidine in this trial experienced a decrease of inflammation within the body and reported earlier […]
Authors: Saima May Sidik 10 February 2022 Massive study shows a long-term, substantial rise in risk of cardiovascular disease, including heart attack and stroke, after a SARS-CoV-2 infection. Even a mild case of COVID-19 can increase a person’s risk of cardiovascular problems for at least a year after diagnosis, a new study1 shows. Researchers found that […]
Here’s how to detox from the COVID spike protein – from the jab or the virus Spike proteins can circulate in your body after infection or injection, causing damage to cells, tissues and organs, but the World Council for Health has compiled a list of medications to prevent this. Thu Dec 23, 2021 – 10:38 […]
Authors: Audrey Dionne, MD1,2; Francesca Sperotto, MD1,2; Stephanie Chamberlain1,2; et alAnnette L. Baker, MSN, CPNP1,2; Andrew J. Powell, MD1,2; Ashwin Prakash, MD1,2; Daniel A. Castellanos, MD1,2; Susan F. Saleeb, MD1,2; Sarah D. de Ferranti, MD, MPH1,2; Jane W. Newburger, MD, MPH1,2; Kevin G. Friedman, MD1,2 JAMA Cardiol. 2021;6(12):1446-1450. doi:10.1001/jamacardio.2021.347 Question What are the findings on cardiac imaging in children with myocarditis after COVID-19 vaccination? Findings In this case series of 15 children who were hospitalized with myocarditis after receipt of the BNT162b2 messenger RNA COVID-19 vaccine for 1 to […]
Authors: Melissa Jenco, News Content Editor August 31, 2021 The risk of myocarditis for children under 16 years is 37 times higher for those infected with COVID-19 than those who haven’t been infected with the virus, according to a new study. Authors from the Centers for Disease Control and Prevention (CDC) said the study provides […]
Authors: Jiong Wang andMartin S. Zand Published online by Cambridge University Press: 13 April 2020 Journal of Clinical and Translational Science>Volume 5 Issue 1 Abstract There is an urgent need for vaccines to the 2019 coronavirus (COVID19; SARS-CoV-2). Vaccine development may not be straightforward, due to antibody-dependent enhancement (ADE). Antibodies against viral surface proteins can, in some […]
Authors: Stephanie Seneff1 and Greg Nigh Computer Science and Artificial Intelligence Laboratory, MIT, Cambridge MA, 02139, USA, E- Naturopathic Oncology, Immersion Health, Portland, OR 97214, ABSTRACT Operation Warp Speed brought to market in the United States two mRNA vaccines, produced by Pfizer and Moderna. Interim data suggested high efficacy for both of these vaccines, which […]
Authors: Wen Shi Lee, Adam K. Wheatley, Stephen J. Kent & Brandon J. DeKosky Nature Microbiology volume 5, pages1185–1191 (2020) Abstract Antibody-based drugs and vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are being expedited through preclinical and clinical development. Data from the study of SARS-CoV and other respiratory viruses suggest that anti-SARS-CoV-2 antibodies could exacerbate COVID-19 through antibody-dependent enhancement (ADE). […]